To assess whether Apelin exerts its effects in the tumor epithelial cells or in the tumor endothelial cells, we used the E0771 mammary cancer model and specifically downregulated the expression of the Apelin receptor (Aplnr) in the cancer cells using shRNA (Fig EV2B). Here, APLN is linked to neoplasm.